Hudson Bay Capital Management

Hudson Bay Capital Management’s Calidi Biotherapeutics CLDI Stock Holding History

Hudson Bay Capital Management’s Portfolio CLDI Stock Details CLDI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,167	Closed	-$5.25M	–	830
2023 Q2	$5.25M	Hold	4,167	–	–	0.05%	301
2023 Q1	$5.13M	Hold	4,167	–	–	0.06%	307
2022 Q4	$5.08M	Buy	+4,167	New	+$4.99M	0.06%	347

Other funds holding CLDI

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $417M AUM 45.61% 1-Year Est. Return

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return

Spectrum Asset Management (California) Newport Beach, California $315M AUM 19.93% 1-Year Est. Return

Red Wave Investments Dillsburg, Pennsylvania $335M AUM 15.13% 1-Year Est. Return

Delta Investment Management San Francisco, California $559M AUM 19.86% 1-Year Est. Return

HRT Financial New York $26B AUM 58.22% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return